Aura Biosciences, Inc. (AURA) Insider Trading
Over the last 3 months, AURA insiders made 0 open-market buys and 3 sales, a net sale of -$39.2M (SEC Form 4). Over the last 6 months, 79 institutions increased and 78 reduced their position (13F).
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
3
Net (3m)
-$39.2M
Insider trades by month Buys Sells
Nov
Jan
Feb
Apr
May
Jun
Context3-month price -7.8%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 16, 2026 | Gibney Anthony Sofficer: See Remarks | Sell | 12,824 | $6.42 |
| Jun 15, 2026 | Johnson David Michaeldirector | Grant | 30,000 | $6.21 |
| Jun 15, 2026 | Mattessich Antony C.director | Grant | 15,000 | — |
| Jun 15, 2026 | Mattessich Antony C.director | Grant | 30,000 | $6.21 |
| Jun 15, 2026 | Johnson David Michaeldirector | Grant | 15,000 | — |
| Jun 15, 2026 | Bitetti Teresa Mariedirector | Grant | 15,000 | — |
| Jun 15, 2026 | Bitetti Teresa Mariedirector | Grant | 30,000 | $6.21 |
| Jun 15, 2026 | Srivastava Sapnadirector | Grant | 15,000 | — |
| Jun 15, 2026 | Srivastava Sapnadirector | Grant | 30,000 | $6.21 |
| May 19, 2026 | Holles Natalie C.director, officer: See Remarks | Grant | 553,844 | — |
| May 19, 2026 | Holles Natalie C.director, officer: See Remarks | Grant | 600,118 | — |
| May 19, 2026 | Holles Natalie C.director, officer: See Remarks | Grant | 2,169,103 | $7.39 |
| May 11, 2026 | Matrix Capital Management Company, LP10 percent owner | Sell | 6,922,870 | $5.64 |
| Apr 16, 2026 | Kilroy Conorofficer: See Remarks | Sell | 11,738 | $7.02 |
| Feb 17, 2026 | Plavsic Markofficer: Chief Technology Officer | Sell | 15,890 | $5.05 |
| Feb 17, 2026 | Hopkins Janet Jillofficer: Chief Medical Officer | Sell | 20,401 | $5.06 |
| Feb 17, 2026 | Elazzouzi Amyofficer: Senior Vice President, Finance | Sell | 8,549 | $5.06 |
| Feb 17, 2026 | de los Pinos Elisabetdirector, officer: See Remarks | Sell | 47,648 | $5.06 |
| Feb 17, 2026 | Kilroy Conorofficer: See Remarks | Sell | 12,079 | $5.05 |
| Jan 20, 2026 | de los Pinos Elisabetdirector, officer: See Remarks | Sell | 16,928 | $4.86 |
| Jan 20, 2026 | Elazzouzi Amyofficer: Senior Vice President, Finance | Sell | 1,581 | $4.86 |
| Nov 17, 2025 | Hopkins Janet Jillofficer: Chief Medical Officer | Sell | 17,109 | $5.42 |
| Oct 29, 2025 | Elazzouzi Amyofficer: Senior Vice President, Finance | Sell | 896 | $6.35 |
| Oct 29, 2025 | de los Pinos Elisabetdirector, officer: See Remarks | Sell | 9,049 | $6.35 |
| Oct 16, 2025 | Plavsic Markofficer: Chief Technology Officer | Sell | 12,169 | $6.35 |
| Aug 18, 2025 | Elazzouzi Amyofficer: Senior Vice President, Finance | Option | 2,319 | $4.25 |
| Aug 18, 2025 | Elazzouzi Amyofficer: Senior Vice President, Finance | Option | 1,094 | $3.16 |
| Aug 18, 2025 | Elazzouzi Amyofficer: Senior Vice President, Finance | Option | 4,744 | $2.74 |
| Aug 18, 2025 | Elazzouzi Amyofficer: Senior Vice President, Finance | Sell | 7,722 | $6.70 |
| Aug 18, 2025 | Elazzouzi Amyofficer: Senior Vice President, Finance | Option | 547 | $5.21 |
Source: AURA SEC Form 4 filings, latest Jun 16, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their AURA positions over the last 6 months (SEC Form 13F).
Increased
79
New positions
38
Reduced
78
Sold out
19
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| MATRIX CAPITAL MANAGEMENT COMPANY, LP | Unchanged | 6.9M | Feb 13, 2026 |
| MATRIX CAPITAL MANAGEMENT COMPANY, LP | Unchanged | 6.9M | May 14, 2026 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | Unchanged | 5.1M | May 15, 2026 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | Unchanged | 5.1M | Feb 13, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | Unchanged | 4.9M | May 15, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | Unchanged | 4.9M | Feb 17, 2026 |
| LONG FOCUS CAPITAL MANAGEMENT, LLC | Unchanged | 4.6M | May 15, 2026 |
| LONG FOCUS CAPITAL MANAGEMENT, LLC | Unchanged | 4.6M | Feb 17, 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Unchanged | 4.4M | Feb 17, 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Unchanged | 4.4M | May 15, 2026 |
| BLACKROCK, INC. | Increased | 3.6M | May 13, 2026 |
| BLACKROCK, INC. | Increased | 3.6M | Feb 12, 2026 |
| MEDICXI VENTURES MANAGEMENT (JERSEY) LTD | Unchanged | 3.0M | Apr 21, 2026 |
| MEDICXI VENTURES MANAGEMENT (JERSEY) LTD | Unchanged | 3.0M | Jan 23, 2026 |
| VANGUARD GROUP INC | Increased | 2.9M | Jan 29, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.